Ovarian Cancer Resection and Debulking in the Upper Abdomen



Ovarian Cancer Resection and Debulking in the Upper Abdomen


Robert W. Holloway

Walter Gotlieb

David Cibula

Kenneth D. Hatch



GENERAL PRINCIPLES

Outcome survival analyses of patients with stage III and IV epithelial ovarian cancer (EOC) have consistently shown that the most important predictor of progression-free and overall survival is the size of residual disease following primary surgery. Optimal resection of ovarian cancer either as primary cytoreductive surgery (CRS) or after neoadjuvant chemotherapy (NACT) may require radical upper abdominal surgery that includes stripping or resection of the diaphragm, splenectomy, or partial pancreatectomy with splenic flexure mobilization for complete omentectomy.




Anatomic Considerations



  • A thorough knowledge of the upper abdominal anatomy is essential to avoid serious complications. The anatomy will be discussed in each of the sections of this chapter and illustrated with the videos.


Nonoperative Management



  • NACT may be considered for patients deemed to be poor candidates for primary CRS.


  • Medical conditions that may be indications for NACT include severe malnutrition with albumin of 2.6 or lower, pre-albumin less than 10 mg/dL, and weight loss of 15% of usual body weight.


  • Serious comorbidities such as COPD, uncorrected coronary artery disease, and morbid obesity may be contraindications.


  • Age over 75 has been reported as a relative contraindication to primary radical debulking surgery.


IMAGING AND OTHER DIAGNOSTICS



  • Many investigators have published results of imaging with CT, MRI, or PET-CT to determine which patients may benefit from NACT and interval debulking.


  • A review of these reports shows that CT and MRI are of equal value and the PET-CT should only be used if there are no findings on CT or MRI and yet ovarian or peritoneal carcinoma is suspected from symptoms and perhaps, elevated biomarkers.


  • Indications for NACT include advanced age with poor performance status, severe malnutrition, stage IV disease (e.g., lung metastases, pleural nodules, liver parenchymal metastases, malignant pleural effusions, mediastinal and supraclavicular node metastases), porta hepatis involvement, and suprarenal node metastasis).


PREOPERATIVE PLANNING



  • We recommend mechanical bowel preparation for patients undergoing debulking procedures, assuming there is no evidence of gastrointestinal obstruction. Clear liquids for 24 hours and oral cathartic have been the standard for many years. Recent literature supports elimination of the oral cathartic even in patients who may have a bowel resection; however, many colorectal surgeons still consider there are significant surgical benefits with the elimination of solid waste in the colon for planned large bowel surgery.


  • Typing and cross-match at least 2 units of packed red blood cells depending on the preoperative hemoglobin and surgeon estimates of radicality or anticipated blood loss. Surgical literature reports blood loss with ovarian debulking procedures that range from 700 to 4,000 cc. Radical debulking surgery should be performed in a hospital that has the capability of rapidly providing additional blood, ICU expertise, and appropriate consultants (e.g., hepatobiliary, vascular, thoracic).



SURGICAL MANAGEMENT

The surgical management section will be in four parts:



  • Laparotomy With Splenectomy


  • Laparotomy With Diaphragm Stripping and Resection


  • Robotic Splenectomy for Recurrent Ovarian Cancer


  • Robotic Diaphragm Stripping and Resection

The video (Video 26.1 image) by Dr. David Cibula shows laparotomy for splenectomy and diaphragm stripping. The video (Video 26.2 image) shows the robotic operations of splenectomy (by Dr. Robert W. Holloway) and the robotic diaphragm (by Dr. Walter Gotlieb).


PART 1: LAPAROTOMY WITH OMENTECTOMY AND SPLENECTOMY


Surgical Management of Splenectomy


Positioning

Supine position


Approach



  • Midline incision to the xiphoid process.


  • Self-retaining upper abdominal retractor.




POSTOPERATIVE CARE FOR SPLENECTOMY

Nasogastric suction is used to prevent dilation of the stomach, which could disrupt the sutures on the gastric vessels. There may be a prolonged ileus that is typical for patients with a major debulking operation. Anemia with hematocrit (Hct) below 25 should be treated with transfusion. Fluid shifts are normal since most patients will have several liters of ascites removed. This leads to a low albumin and low urinary output. Conservative use of crystalloid and more reliance on blood products has been our policy. This will avoid fluid overload and pulmonary edema. Enoxaparin should be withheld until the Hct is stable.


COMPLICATIONS FOR SPLENECTOMY

Pleural effusion, atelectasis of the left lung, pneumonia, hemorrhage, and splenic vein thrombosis have been reported. A subphrenic abscess is most likely the result of injury to the stomach or the colonic at the splenic flexure. Pancreatic fistula or pseudocyst has been reported in 27% of patients. The rate was decreased to 4% when a polyethylene glycolic felt with fibrin sealant was placed. Postsplenectomy syndrome leads to a hypercoagulable state with a rise in platelets above 750,000 and increase in clotting risk. Monitoring platelets daily will identify the problem. Sepsis due to pneumococcus may occur. For this reason, patients should be given pneumococcal vaccine. Meningococcal and Haemophilus influenza vaccines are also recommended.


May 7, 2019 | Posted by in GYNECOLOGY | Comments Off on Ovarian Cancer Resection and Debulking in the Upper Abdomen

Full access? Get Clinical Tree

Get Clinical Tree app for offline access